PPT-Substantial Equivalence – Where do we Stand?

Author : tatyana-admore | Published Date : 2016-06-12

Stacy Ehrlich Partner Kleinfeld Kaplan amp Becker LLP Ben Haas Partner Latham amp Watkins LLP Moderated by Dean R Cirotta MBA President amp COO EAS Consulting

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Substantial Equivalence – Where do we ..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Substantial Equivalence – Where do we Stand?: Transcript

Stacy Ehrlich Partner Kleinfeld Kaplan amp Becker LLP Ben Haas Partner Latham amp Watkins LLP Moderated by Dean R Cirotta MBA President amp COO EAS Consulting Group Substantial . Document issued on July 15 2014 You should submit comments and suggestions regarding this draft document within 90 days of publication in the Federal Register of the no tice announcing the availability of the draft guidance Submit comments to the Di Where people have substantial difficulty in being involved in the key care and support processes of assessment care andor support planning care reviews and safeguarding enquires and safeguarding adult reviews the local authority must enable them to Demonstrating the Substantial Equivalence of a New Tobacco Product: . Alternatively, submit written comments to the Division of Dockets Management (H305), Food and Drug Administration, 5630 Fishers Substantial Changes form. In addition, the procedure for approval of new courses must be followed for each new course. The program change (including new or revised course outlines) is reviewed by the Don Glondys, CFM. RAMPP. FEMA Region. III National Flood Insurance Program (NFIP) Essentials and Best Practices. Agenda. Intent of . the Substantial Improvement . (SI) provision. Defining SI. 1. 1. http://www.accessdata.fda.gov/cdrh_docs/pdf/P980048b.pdf. The . views and opinions expressed in the following PowerPoint slides are those of . the individual . presenter and should not be attributed to Drug Information Association, Inc. (“DIA”), its directors, officers, employees, volunteers, members, . Historically, equivalence has represented one of the essential problems facing translation theory, since translation deals with two languages, each of which has its own characteristic features at the levels of phonetics, phonology, grammar, semantics, culture, . DECISION SUMMARY ASSAY AND INSTRUMENT COMBINATION TEMPLATE A. 510(k) Number: k070524 B. Purpose for Submission: New Device C. Measurand: Glucose D. Type of Test: Quantitative (Glucose Dehydro Professor Philip Bradley. School of Medical Education. Teaching and Learning Conference March 2015. NUMed’s. mission. To provide affordable UK undergraduate medical education in Malaysia for Malaysian and International students (not UK or EU). Anthony Pym . Master of Translation . . Your questions: . Master of Translation . . Your questions: . Master of Translation . . Your questions on interdisciplinarity: . Master of Translation . How . 25/2/2016. Director of Medical Ethics. Oxford Uehiro Centre. Dominic.wilkinson@philosophy.ox.ac.uk. @Neonatalethics. Case 1. Jim. https://vimeopro.com/usmedinnov/surgicalprocedures. http://www.atlantamedcenter.com/en-US/ourServices/medicalServices/BloodlessMedicineSurgery/Pages/default.aspx. DECISION SUMMARY ASSAY AND INSTRUMENT COMBINATION TEMPLATE A. 510(k) Number: k072816 B. Purpose for Submission: New Device C. Measurand: Breath Nitric Oxide D. Type of Test: Quantitative SubtestInputaOutputbDirect evidencecEvidence for similar taskscSimilaritiesBSD GD PS BSR MC OE PR SPRT 7 8 11 D 1 2 3 4 5 6 7150VC 14150Oral Vocabulary OV General Information GI 15Guess What GW Verbal Design considerations and sample size. Demonstrated on . Head of Statistics. nQuery. Lead Researcher. FDA Guest Speaker. Guest Lecturer. Webinar Host. HOSTED BY: . Ronan Fitzpatrick. AGENDA. Background.

Download Document

Here is the link to download the presentation.
"Substantial Equivalence – Where do we Stand?"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.